vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与PEOPLES BANCORP INC（PEBO）财务数据对比。点击上方公司名可切换其他公司
PEOPLES BANCORP INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$118.7M vs $75.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 3.7%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
该公司是总部位于美国明尼苏达州明尼阿波利斯、在特拉华州注册的美国跨国银行机构。截至2025年，它是美国第五大银行，同时也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构。它主营银行、投资、抵押贷款等相关金融业务。
PBYI vs PEBO — 直观对比
营收规模更大
PEBO
是对方的1.6倍
$75.5M
两年增速更快
PBYI
近两年复合增速
3.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $118.7M |
| 净利润 | — | $29.0M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | — |
| 净利率 | — | 24.4% |
| 营收同比 | 27.7% | — |
| 净利润同比 | — | -8.7% |
| 每股收益（稀释后） | $0.26 | $0.81 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIPEBO
| Q1 26 | — | $118.7M | ||
| Q4 25 | $75.5M | $117.3M | ||
| Q3 25 | $54.5M | $115.2M | ||
| Q2 25 | $52.4M | $114.5M | ||
| Q1 25 | $46.0M | $112.4M | ||
| Q4 24 | $59.1M | $111.6M | ||
| Q3 24 | $80.5M | $113.7M | ||
| Q2 24 | $47.1M | $110.3M |
净利润PBYIPEBO
| Q1 26 | — | $29.0M | ||
| Q4 25 | — | $31.8M | ||
| Q3 25 | $8.8M | $29.5M | ||
| Q2 25 | $5.9M | $21.2M | ||
| Q1 25 | $3.0M | $24.3M | ||
| Q4 24 | — | $26.9M | ||
| Q3 24 | $20.3M | $31.7M | ||
| Q2 24 | $-4.5M | $29.0M |
毛利率PBYIPEBO
| Q1 26 | — | — | ||
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — |
营业利润率PBYIPEBO
| Q1 26 | — | — | ||
| Q4 25 | 22.7% | 32.4% | ||
| Q3 25 | 17.6% | 33.0% | ||
| Q2 25 | 12.7% | 24.0% | ||
| Q1 25 | 8.7% | 27.9% | ||
| Q4 24 | 22.6% | 31.2% | ||
| Q3 24 | 27.4% | 36.0% | ||
| Q2 24 | -4.6% | 32.5% |
净利率PBYIPEBO
| Q1 26 | — | 24.4% | ||
| Q4 25 | — | 27.1% | ||
| Q3 25 | 16.2% | 25.6% | ||
| Q2 25 | 11.2% | 18.5% | ||
| Q1 25 | 6.5% | 21.7% | ||
| Q4 24 | — | 24.1% | ||
| Q3 24 | 25.2% | 27.9% | ||
| Q2 24 | -9.6% | 26.3% |
每股收益（稀释后）PBYIPEBO
| Q1 26 | — | $0.81 | ||
| Q4 25 | $0.26 | $0.89 | ||
| Q3 25 | $0.17 | $0.83 | ||
| Q2 25 | $0.12 | $0.59 | ||
| Q1 25 | $0.06 | $0.68 | ||
| Q4 24 | $0.40 | $0.76 | ||
| Q3 24 | $0.41 | $0.89 | ||
| Q2 24 | $-0.09 | $0.82 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $82.9M |
| 总债务越低越好 | $22.7M | $691.3M |
| 股东权益账面价值 | $130.3M | $1.2B |
| 总资产 | $216.3M | $9.6B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.57× |
8季度趋势，按日历期对齐
现金及短期投资PBYIPEBO
| Q1 26 | — | $82.9M | ||
| Q4 25 | $97.5M | $189.0M | ||
| Q3 25 | $94.4M | $190.2M | ||
| Q2 25 | $96.0M | $186.1M | ||
| Q1 25 | $93.2M | $187.0M | ||
| Q4 24 | $101.0M | $217.7M | ||
| Q3 24 | $96.7M | $283.7M | ||
| Q2 24 | $96.8M | $235.9M |
总债务PBYIPEBO
| Q1 26 | — | $691.3M | ||
| Q4 25 | $22.7M | $204.1M | ||
| Q3 25 | $34.0M | $227.3M | ||
| Q2 25 | $45.3M | $232.4M | ||
| Q1 25 | $56.7M | $237.0M | ||
| Q4 24 | $68.0M | $238.1M | ||
| Q3 24 | $79.3M | $236.8M | ||
| Q2 24 | $90.7M | $234.3M |
股东权益PBYIPEBO
| Q1 26 | — | $1.2B | ||
| Q4 25 | $130.3M | $1.2B | ||
| Q3 25 | $115.3M | $1.2B | ||
| Q2 25 | $104.7M | $1.2B | ||
| Q1 25 | $97.1M | $1.1B | ||
| Q4 24 | $92.1M | $1.1B | ||
| Q3 24 | $71.1M | $1.1B | ||
| Q2 24 | $48.5M | $1.1B |
总资产PBYIPEBO
| Q1 26 | — | $9.6B | ||
| Q4 25 | $216.3M | $9.6B | ||
| Q3 25 | $202.9M | $9.6B | ||
| Q2 25 | $194.9M | $9.5B | ||
| Q1 25 | $196.2M | $9.2B | ||
| Q4 24 | $213.3M | $9.3B | ||
| Q3 24 | $220.7M | $9.1B | ||
| Q2 24 | $205.0M | $9.2B |
负债/权益比PBYIPEBO
| Q1 26 | — | 0.57× | ||
| Q4 25 | 0.17× | 0.17× | ||
| Q3 25 | 0.30× | 0.19× | ||
| Q2 25 | 0.43× | 0.20× | ||
| Q1 25 | 0.58× | 0.21× | ||
| Q4 24 | 0.74× | 0.21× | ||
| Q3 24 | 1.12× | 0.21× | ||
| Q2 24 | 1.87× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | — |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYIPEBO
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $134.7M | ||
| Q3 25 | $9.7M | $14.4M | ||
| Q2 25 | $14.1M | $50.7M | ||
| Q1 25 | $3.6M | $34.3M | ||
| Q4 24 | $15.6M | $143.2M | ||
| Q3 24 | $11.0M | $34.1M | ||
| Q2 24 | $1.0M | $32.1M |
自由现金流PBYIPEBO
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $128.7M | ||
| Q3 25 | $9.7M | $12.7M | ||
| Q2 25 | $14.1M | $49.2M | ||
| Q1 25 | $3.6M | $31.5M | ||
| Q4 24 | $15.6M | $136.4M | ||
| Q3 24 | $11.0M | $33.2M | ||
| Q2 24 | $1.0M | $30.2M |
自由现金流率PBYIPEBO
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | 109.7% | ||
| Q3 25 | 17.7% | 11.0% | ||
| Q2 25 | 26.8% | 43.0% | ||
| Q1 25 | 7.7% | 28.1% | ||
| Q4 24 | 26.4% | 122.2% | ||
| Q3 24 | 13.7% | 29.2% | ||
| Q2 24 | 2.1% | 27.4% |
资本支出强度PBYIPEBO
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 5.1% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 1.3% | ||
| Q1 25 | 0.1% | 2.4% | ||
| Q4 24 | 0.0% | 6.1% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.0% | 1.7% |
现金转化率PBYIPEBO
| Q1 26 | — | — | ||
| Q4 25 | — | 4.24× | ||
| Q3 25 | 1.10× | 0.49× | ||
| Q2 25 | 2.41× | 2.39× | ||
| Q1 25 | 1.21× | 1.41× | ||
| Q4 24 | — | 5.32× | ||
| Q3 24 | 0.54× | 1.08× | ||
| Q2 24 | — | 1.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
PEBO
| Net Interest Income | $90.4M | 76% |
| Noninterest Income | $28.3M | 24% |
